Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-12-17

Clinical Trial Update: Investigator Initiated Trial Using Dry Eye Surveys to Evaluate and Better Understand FDA Approved Acoltremon Treatment for Dry Eye Disease in Real World Treatment Settings (DESERT) [Phase 4]

View source ↗

Summary

This is an investigator-initiated Phase 4 trial (DESERT) to evaluate the real-world use of the FDA-approved Acoltremon for Dry Eye Disease; the study is not yet…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Acoltremon

Snippet

Sponsor: Center for Sight Las Vegas | Conditions: Dry Eye Disease (DED) | Phase 4 | Status: NOT_YET_RECRUITING